ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Thursday reported a loss of $90.1 million in its first quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of $1.72.
The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.36 per share.
The biotechnology company posted revenue of $6.4 million in the period, which also did not meet Street forecasts. Five analysts surveyed by Zacks expected $23.8 million.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/RGNX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
